Related Experiment Video
Updated: May 30, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner
Utpal B Pajvani1, Carrie J Shawber, Varman T Samuel
1Department of Medicine, Columbia University, New York, New York, USA.
Abstract:
Transcription factor FoxO1 promotes hepatic glucose production. Genetic inhibition of FoxO1 function prevents diabetes in experimental animal models, providing impetus to identify pharmacological approaches to modulate this function. Altered Notch signaling is evident in tumorigenesis, and Notch antagonists are in clinical testing for application in cancer. Here we report that FoxO1 and Notch coordinately regulate hepatic glucose metabolism. Combined haploinsufficiency of FoxO1 and Notch1 markedly raises insulin sensitivity in diet-induced insulin resistance, as does liver-specific knockout of the Notch transcriptional effector Rbp-Jκ. Conversely, Notch1 gain-of-function promotes insulin resistance in a FoxO1-dependent manner and induces glucose-6-phosphatase expression. Pharmacological blockade of Notch signaling with γ-secretase inhibitors raises insulin sensitivity after in vivo administration in lean mice and in obese, insulin-resistant mice. The data identify a heretofore unknown metabolic function of Notch and suggest that Notch inhibition is beneficial in diabetes treatment, in part by helping to offset excessive FoxO1-driven hepatic glucose production.
Insights
Notch signaling inhibition improves insulin sensitivity by reducing hepatic glucose production, offering a new therapeutic strategy for diabetes. This approach targets the interplay between FoxO1 and Notch pathways.
Area of Science:
- Metabolic regulation
- Molecular endocrinology
- Signaling pathways
Background:
- Transcription factor FoxO1 is a key regulator of hepatic glucose production, making it a target for diabetes treatment.
- Notch signaling alterations are implicated in cancer, with antagonists in clinical trials.
- The interplay between FoxO1 and Notch in metabolic regulation is largely unexplored.
Purpose of the Study:
- To investigate the coordinated roles of FoxO1 and Notch signaling in regulating hepatic glucose metabolism.
- To determine the therapeutic potential of modulating Notch signaling for insulin resistance and diabetes.
Main Methods:
- Genetic manipulation including combined haploinsufficiency of FoxO1 and Notch1, and liver-specific knockout of Rbp-Jκ.
- In vivo administration of γ-secretase inhibitors to block Notch signaling.
- Assessment of insulin sensitivity and hepatic glucose production in mouse models of diet-induced obesity and insulin resistance.
Main Results:
- Combined haploinsufficiency of FoxO1 and Notch1, or knockout of Rbp-Jκ, significantly improved insulin sensitivity in diet-induced insulin-resistant mice.
- Notch1 gain-of-function exacerbated insulin resistance in a FoxO1-dependent manner and increased glucose-6-phosphatase expression.
- Pharmacological inhibition of Notch signaling using γ-secretase inhibitors enhanced insulin sensitivity in both lean and obese mice.
Conclusions:
- Notch signaling plays a previously unrecognized role in hepatic glucose metabolism.
- Inhibition of Notch signaling is a promising therapeutic strategy for diabetes, partly by counteracting FoxO1-mediated hepatic glucose production.
- Targeting the Notch pathway offers a novel approach to improve insulin sensitivity and manage metabolic dysfunction.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
PI3K/mTOR/AKT Signaling Pathway
Insulin: The Receptor and Signaling Pathways
Regulation of Angiogenesis and Blood Supply
